Heim1PG • FRA
add
Aker Biomarine ASA
Við síðustu lokun
5,56 €
Dagbil
5,63 € - 5,63 €
Árabil
3,80 € - 8,91 €
Meðalmagn
39,00
V/H-hlutf.
-
A/V-hlutfall
-
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Tekjur | 50,80 m. | 4,74% |
Rekstrarkostnaður | 20,20 m. | -11,79% |
Nettótekjur | -3,10 m. | 73,95% |
Hagnaðarhlutfall | -6,10 | 75,14% |
Hagnaður á hvern hlut | — | — |
EBITDA | 4,10 m. | -57,73% |
Virkt skatthlutfall | -42,86% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 16,00 m. | -50,00% |
Heildareignir | 389,60 m. | -52,11% |
Heildarskuldir | 219,00 m. | -52,27% |
Eigið fé alls | 170,60 m. | — |
Útistandandi hlutabréf | 87,69 m. | — |
Eiginfjárgengi | 2,85 | — |
Arðsemi eigna | -0,13% | — |
Ávöxtun eigin fjár | -0,15% | — |
Peningaflæði
Breyting á handbæru fé
| (USD) | mar. 2025info | Breyting á/á |
|---|---|---|
Nettótekjur | -3,10 m. | 73,95% |
Handbært fé frá rekstri | -10,90 m. | -626,67% |
Reiðufé frá fjárfestingum | -2,60 m. | 43,48% |
Reiðufé frá fjármögnun | 14,50 m. | 38,10% |
Breyting á handbæru fé | 1,00 m. | -77,27% |
Frjálst peningaflæði | -11,14 m. | -474,37% |
Um
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, FloraMarine, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION and Understory. Aker BioMarine is listed on the Oslo Stock Exchange. Wikipedia
Framkvæmdastjóri
Stofnsett
2006
Vefsvæði
Starfsfólk
249
